Fluticasone furoate/Vilanterol 92/22 μg once-a-day vs Beclomethasone dipropionate/Formoterol 100/6 μg b.I.D.: a 12-month comparison of outcomes in mild-to-moderate asthma

Fluticasone furoate/Vilanterol 92/22 μg once-a-day vs Beclomethasone dipropionate/Formoterol 100/6 μg b.I.D.: a 12-month comparison of outcomes in mild-to-moderate asthma

Abstract Background Bronchial asthma is an inflammatory disease of the airways. Beclomethasone dipropionate/Formoterol (BDP/F) and Fluticasone furoate/Vilanterol (FF/V) are two of the most effective LABA/ICS combinations for managing persistent bronchial asthma. Aim of the study was to compare the o...

Full description

Bibliographic Details
Main Authors: Roberto W. Dal Negro, Luca Bonadiman, Paola Turco
Format: Article
Language:English
Published: PAGEPress Publications 2018-06-01
Series:Multidisciplinary Respiratory Medicine
Subjects:
Adherence to treatment
Beclomethasone dipropionate/Formoterol
Clinical outcomes
Fluticasone furoate/Vilanterol
Mild-to-moderate asthma
Time dependency
Online Access:http://link.springer.com/article/10.1186/s40248-018-0131-x

Internet

http://link.springer.com/article/10.1186/s40248-018-0131-x

Similar Items